No Data
No Data
No Data
No Data
No Data
IVD MEDICAL: Annual Report 2023
Futu NewsApr 10 17:26 · Announcements
Huajian Healthcare (01931): Chen Shauji and Law Jianhui appointed as executive directors
Huajian Medical (01931) issued an announcement. Since March 28, 2024, Liu Shaoji has resigned as an independent non-executive director...
Zhitong FinanceMar 29 02:57
Featured announcements | Fuyao Glass's net profit in 2023 increased 18.37% year on year; passenger occupancy rates of the three major airlines all recovered to more than 80% in February
Meitu's adjusted net profit in 2023 was about 370 million yuan, up 233.2% year on year; Longhu Group's total contract sales amount for February was 5.75 billion yuan.
Futu NewsMar 18 08:04
IVD MEDICAL To Go Ex-Dividend On May 20th, 2024 With 0.06209 HKD Dividend Per Share
March 16th - $IVD MEDICAL(01931.HK)$ is trading ex-dividend on May 20th, 2024. Shareholders of record on May 21st, 2024 will receive 0.06209 HKD dividend per share on May 29th, 2024. The ex-divide
Futu NewsMar 16 17:05
Huajian Healthcare (01931) will pay a final dividend of HK$0.06209 per share on May 29
Huajian Medical (01931) issued an announcement that it will be distributed on May 29, 2024 until December 3, 2023...
Zhitong FinanceMar 15 21:49
Profit attributable to owners of Huajian Healthcare (01931.HK)'s 2023 parent company increased 13.4% year-on-year
Gelonghui, March 15, 丨 Huajian Medical (01931.HK) announced that for the year ended December 31, 2023, the Group recorded revenue of RMB 3,089 billion, an increase of 12.4% over the same period in 2022. Profit attributable to owners of parent companies was RMB 238 million, an increase of 13.4% over the same period in 2022. The increase in revenue is mainly due to increased demand for IVD products from end customers, which is due to the gradual return of hospital operations to normal after COVID-19. The increase in profit during the year was mainly due to (i) increased earnings; and (ii) share award schemes
Gelonghui FinanceMar 15 21:47
No Data
No Data